MedTrace Logo

Management of Drug-resistant Epilepsy in Infants and Children: a Real-life Study of the Use of the Ketogenic Diet in France and the KetoCal® Range in Its Maintenance

NCT06075485 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2024-01-24

No results posted yet for this study

Summary

This is a multicenter, prospective, observational, longitudinal study designed to describe the therapeutic value of the KetoCal® range in the maintenance of a ketogenic diet during the management of infants (from 5 months) and children up to 17 years of age (i.e. 18 years minus 1 day) with drug-resistant epilepsy.

This study is being conducted according to standard medical practice. No change in diagnostic or therapeutic management habits is imposed by this study. Quality of life questionnaires are the only additional procedures for this research.

Conditions

  • Drug Resistant Epilepsy
  • Ketogenic Dieting

Interventions

OTHER

Ketocal

ketogene diet

Sponsors & Collaborators

  • Euraxi Pharma

    collaborator INDUSTRY

  • Nutricia Nutrition Clinique

    lead INDUSTRY

Eligibility

Min Age
5 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06075485 on ClinicalTrials.gov